Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 398 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: hemoglobin A1c Clear all

Conditions: Diabetes Mellitus, Type 2
Interventions: Pioglitazone; Drug
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Type 2 Diabetes, Obesity
Interventions: discontinuation of sugar sweetened beverages; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), Hyperglycemia, Insulin Dependent Diabetes
Interventions: Hemoglobin A1c, Observation Unit; Diagnostic Test · Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 21 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Type1diabetes
Interventions: AHCL pump, Video conferencing Application; Device · Other
Lead sponsor: Children's Hospital New Orleans, LA; Other
Eligibility: 10 Years to 17 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Diabetes Mellitus, Type 2
Interventions: Pharmacy Managed Diabetes Clinic (PMDC), Standard of Care (SOC); Behavioral · Other
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 75 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 4
States / cities: Berkley, Michigan • Royal Oak, Michigan • Southfield, Michigan + 1 more

Conditions: Cardiovascular Disease Prevention, Cardiometabolic Diseases, Cardiovascular Risk Factor, Cardiovascular Risk Score, Hypertension, Hyperlipidemia, Diabetes, Lifestyle Modification, Health Coaching
Interventions: Longitudinal, Individualized Health Coaching; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 40 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasm
Interventions: Screening Blood Tests, Endoscopic Ultrasound, Magnetic Resonance Imaging, Magnetic Resonance Cholangiopancreatography; Other · Diagnostic Test · Combination Product
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2041
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Type 2 Diabetes Mellitus
Interventions: Vitamin D3 2000 international units daily, Vitamin C 500mg daily; Dietary Supplement
Lead sponsor: ProMedica Health System; Other
Eligibility: 21 Years to 75 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 3
States / cities: Sylvania, Ohio • Toledo, Ohio

Conditions: Diabetes Mellitus
Interventions: "Diabetes Report Card"; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Prediabetes
Interventions: Empagliflozin 10mg daily, Lifestyle education; Drug · Other
Lead sponsor: Charles George VA Medical Center; Federal
Eligibility: 35 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Asheville, North Carolina

Conditions: Diabetes Mellitus Type 2
Interventions: Placebo, RO4876904; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 289 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 12
States / cities: Hot Springs, Arkansas • Concord, California • Los Angeles, California + 9 more

Conditions: Hemoglobins, Diagnostic Tests
Interventions: MyChart message; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 100 Years
Enrollment: 2,403 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes Mellitus, Type 1, Autoimmune Diseases, Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, Immune System Diseases, Metabolic Diseases
Interventions: Glutamine vs. Placebo, Exercise; Drug · Behavioral
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 13 Years to 19 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Type 2 Diabetes Mellitus, Diabetic Kidney Disease, Adolescent Obesity, Pre Diabetes, Kidney Hypoxia, Puberty
Interventions: Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/ML, Dextran 40; Drug
Lead sponsor: Petter Bjornstad; Other
Eligibility: 8 Years to 14 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Aurora, Colorado • Seattle, Washington

Conditions: Uncontrolled Diabetes, Uncontrolled Hypertension
Interventions: CHC-level cluster randomized control trial; Other
Lead sponsor: Morehouse School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 72,726 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Miami, Florida • Atlanta, Georgia • Portland, Oregon

Conditions: Type 2 Diabetes
Interventions: Targeted Self-Monitoring Of Blood Glucose (SMBG), Provider Training, Patient Education; Other
Lead sponsor: Biomedical Research Institute of New Mexico; Other
Eligibility: 18 Years to 85 Years
Enrollment: 348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 3
States / cities: Phoenix, Arizona • Tucson, Arizona • Albuquerque, New Mexico

Conditions: Physician Workflow, Resource Utilization
Interventions: OPA; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Not listed
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Adipose Tissue, Brown, Adipose Tissue, Obesity
Interventions: Fat biopsy, Blood sampling, Blood sample for DNA analysis; Procedure · Diagnostic Test · Genetic
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 2 Diabetes
Interventions: FreeStyle Libre 2/Libre 3+ Continuous Glucose Monitor; Device
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Diabetes Mellitus, Type 2
Interventions: Dulce Digital, Dulce Digital-Me (Automated Delivery), Dulce Digital-Me (Medical Assistant); Behavioral
Lead sponsor: Scripps Whittier Diabetes Institute; Other
Eligibility: 18 Years and older
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: Chula Vista, California • La Jolla, California

Conditions: Diabetes Mellitus, Type 2
Interventions: Bexagliflozin tablets, Bexagliflozin tablets, placebo; Drug
Lead sponsor: Theracos; Industry
Eligibility: 20 Years and older
Enrollment: 292 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 32
States / cities: Peoria, Arizona • Tucson, Arizona • Canoga Park, California + 29 more

Conditions: PreDiabetes
Interventions: Metabolic Rheostat, Butyrate Ultra, Placebo; Dietary Supplement
Lead sponsor: Zhaoping Li; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetes Mellitus, Type 2
Interventions: My Diabetes Care Mobile (MDC-m); Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Type2 Diabetes, Type 2 Diabetes Mellitus in Obese, Dysglycemia, Microvascular Complications, Brain Structure, Obesity, Childhood, Diabetes in Adolescence, Inflammation, Insulin Resistance, Overweight, Childhood, Cognitive Decline
Interventions: Observational; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 12 Years to 17 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 2
States / cities: St Louis, Missouri • Pittsburgh, Pennsylvania

Search by objective public record fields.

"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM

Effect of Discontinuation of Sugar Sweetened Beverages

Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED

Defining the Role of Management Factors in Outcome Disparity in Pediatric T1D

Impact of Pharmacy Clinic on Diabetes Management

Preventative Screening and Health Coaching in a Food Insecure Population

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus

New Ways to Help Patients Improve Their Diabetes Control

Evaluation of Empagliflozin vs Standard Care in Veterans With Prediabetes

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

Electronic Triggers: Messaging After A1C EHR Alert

Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.

Impact of Accu-Chek 360 in Veterans With Type 2 Diabetes

Evaluating a Our Practice Advisory (OPA) to Optimize Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) Test Orders

The Physiology of Human Brown Adipose Tissue

Pharmacist-led Continuous Glucose Monitoring

Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes

A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus

Study to Determine the Effect of Synbiotics in Patients With Pre-diabetes

My Diabetes Care Mobile: A Usability Study

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)